TSMC (2330 TT) July Revenue (TWD) 467.8bln, +44.7% Y/Y; YTD Revenue 2.87tln
Newsquawk Staff ·
TSMC (2330 TT) July Revenue (TWD) 467.8bln, +44.7% Y/Y; YTD Revenue 2.87tln.
What it means
TSMC's monthly revenue prints have long functioned as the market's highest-frequency read on foundry and advanced-node demand, and a growth rate of this magnitude is consistent with the pattern of prior AI-led upcycles, in which strength concentrated in leading-edge process capacity has carried the headline well ahead of the broader semiconductor peer set. Because TSMC reports revenue monthly but margins only quarterly, the usual sequence is for the revenue print to be absorbed quickly and for positioning to shift to the quarterly release, where gross margin, capex guidance and the high-performance-computing versus smartphone mix historically do the actual repricing work. The distinction worth drawing is between volume-led growth, which supports the whole supply chain, and price- and mix-led growth at the most advanced nodes, which concentrates the benefit. The print also serves as a proxy input for large customers whose own AI accelerator roadmaps depend on TSMC capacity, so follow-on reads tend to come through those names' commentary and through any signals on advanced packaging constraints. Worth noting that the tag list mixes in unrelated tickers sharing the TT symbol; the print itself pertains solely to the foundry.
- US President Trump invokes Section 232 on wind turbine imports
- US President Trump signs EO on housing costs, aiming to cut mortgage insurance premiums
- US BROKER MOVES: CME upgraded at JPM; BROS downgraded at RBC
- Honeywell (HON) says it is on track to remove all remaining stranded costs by end-2026, adding that it is positioning itself for continued fixed cost productivity in 2027
- Honeywell International Inc. (HON) Q3 2026 (USD): Adj. EPS 2.27 (exp. 2.17), Revenue 5bln (exp. 5.01bln)
Related headlines
- Merck & Co (MRK) and Moderna (MRNA) say safety profile of Intismeran plus Keytruda was generally consistent with previously reported studies of combination; significantly reduced the risk of recurrence or death by 42% compared to Keytruda alone1 hour ago
- US President Trump called Musk and asked him to lift Ukraine Starlink (SPCX) restrictions, WSJ reports2 hours ago
- Moderna (MRNA) downside attributed to early data leaks (link below) - UNCONFIRMED3 hours ago
- State of Rhode Island sues Meta (META) over alleged tolerance for scam advertising4 hours ago
- Uber (UBER) puts all 30,000 employees on ChatGPT Work4 hours ago
- Newsquawk Daily US Earnings Estimates - 23rd October 2026: AXP4 hours ago
- US President Trump says "Iran is doing everything they can to drive up the price of Oil prior to the U.S. Midterm Election". 4 hours ago
- Nvidia (NVDA) launches Minerva platform for end-to-end AI factory observability5 hours ago
- Fireblocks denies talks with Visa (V), CoinDesk reports5 hours ago
- Norfolk Southern (NSC) says tightening truck capacity is improving rail competitiveness, supporting truck-to-rail conversions and stronger customer demand6 hours ago
- US EQUITY OPEN: Mag-7 earnings lead Tech and Indices lower as the Middle East situation remains fragile6 hours ago
- Infineum is exploring a USD 8bln sale, the FT reports6 hours ago
- Procter & Gamble (PG) CFO says 'so far, consumer has held up, we don't know if that's going to continue'6 hours ago
- Meta's (META) 5yr CDS hits an all-time high at 114.5bps6 hours ago
- eBay (EBAY) confirms plans to reduce workforce by 9%; expects Q3 results above guidance 7 hours ago